Related Experiment Video

Updated: May 15, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

[Characteristics of pediatric C3 glomerulopathy with decreased factor H in 3 cases]

Rui-juan He1, Hui-jie Xiao, Su-xia Wang

  • 1Department of Pediatrics, First Hospital, Peking University, Beijing 100034, China.

Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics
|January 18, 2013
PubMed

Insights

This study examines three pediatric C3 glomerulopathy cases, revealing varied clinical and pathological features. Complement system dysregulation, indicated by low C3 and Factor H, is crucial in pediatric C3 glomerulopathy.

Area of Science:

  • Pediatric Nephrology
  • Complement System Biology
  • Glomerular Diseases

Context:

  • C3 glomerulopathy (C3G) is a rare kidney disease characterized by complement C3 deposition.
  • Understanding pediatric C3G is limited due to scarce case reports.
  • This study focuses on the clinicopathological characteristics and prognosis of pediatric C3G.

Purpose:

  • To investigate the clinicopathological features of three pediatric C3 glomerulopathy cases.
  • To analyze the prognosis and treatment responses in these children.
  • To enhance the understanding of C3 glomerulopathy in a pediatric population.

Summary:

  • Three pediatric cases of C3 glomerulopathy were analyzed for clinical presentation, renal biopsy findings, and treatment outcomes.
  • All cases showed C3 deposition in glomeruli, with varied presentations including hematuria and proteinuria.
  • Decreased plasma C3 and Factor H (FH) levels were observed, suggesting complement dysregulation.

Impact:

  • Highlights the diverse clinical and pathological spectrum of pediatric C3 glomerulopathy.
  • Emphasizes the role of complement system abnormalities in the pathogenesis of C3G.
  • Provides insights into the management and prognosis of C3G in children.
Abstract

More Related Videos

An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney10:14

An Efficient Sieving Method to Isolate Intact Glomeruli from Adult Rat Kidney

Published on: November 1, 2018

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...